TELA Bio, Inc.
TELA
$1.27
-$0.03-2.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.91% | -22.33% | 11.22% | 17.68% | -122.58% |
| Total Depreciation and Amortization | 1.12% | 0.38% | 1.14% | 5.62% | 6.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.39% | -24.91% | 32.31% | 19.12% | 127.02% |
| Change in Net Operating Assets | 163.39% | 45.07% | -43.01% | -918.89% | 102.84% |
| Cash from Operations | 18.71% | -29.13% | 16.16% | 16.02% | 25.63% |
| Capital Expenditure | -256.25% | 87.88% | -116.39% | 59.20% | 1.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.06% | 103.17% | -- | -100.00% | -92.68% |
| Cash from Investing | 47.83% | 172.63% | -55.74% | -282.09% | -98.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -99.86% | 36,582.91% | 1,850.00% | -98.44% |
| Repurchase of Common Stock | 98.31% | -1,509.09% | 42.11% | -72.73% | 96.65% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.41% | -100.27% | 43,683.67% | 2,060.00% | -108.93% |
| Foreign Exchange rate Adjustments | -13.43% | -173.63% | 196.81% | -1,466.67% | -126.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.14% | -127.81% | 484.65% | 13.64% | -11.07% |